O'Dell Group’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,200
Closed -$11.8K 398
2023
Q4
$11.8K Buy
+1,200
New +$11.8K ﹤0.01% 335
2023
Q3
Sell
-1,175
Closed -$8.78K 393
2023
Q2
$8.78K Buy
+1,175
New +$8.78K ﹤0.01% 353
2022
Q4
Sell
-1,175
Closed -$13K 329
2022
Q3
$13K Buy
+1,175
New +$13K ﹤0.01% 272